How much funding has CereVasc raised?

CereVasc has raised $278.9M in total funding, most recently a Series C round.

Who are CereVasc's investors?

CereVasc's investors include Bain Capital Life Sciences, Perceptive Advisors, Covidien Ventures, Longwood Fund.

Where is CereVasc headquartered?

CereVasc is headquartered in Boston, Massachusetts, United States.

What industry is CereVasc in?

CereVasc operates in Healthcare, Medical Devices.

CereVasc

Leadership in Cerebrospinal Fluid (CSF) Management, Access, and Therapy

Boston, United States · Founded 2014 · $278.9M raised

Healthcare

Medical Devices

Headquarters: Boston, Massachusetts
Employees: 11–50
Founded: 2014
Business Model: B2B

Website: cerevasc.com
Total Funding: $278.9M
Last Round: $85.0M Series CJun 2026
Rounds: 6

About

CereVasc is a clinical-stage medical device company developing the eShunt System, a minimally invasive endovascular treatment for communicating hydrocephalus and other CSF disorders. The percutaneous transvenous-transdural approach avoids open neurosurgery.

Summary

CereVasc is a Healthcare company based in Boston, United States, founded in 2014. It has raised $278.9M in total across 6 rounds, most recently a $85.0M Series C round in Jun 2026. Investors include Bain Capital Life Sciences, Perceptive Advisors and Covidien Ventures.

LinkedIn X (Twitter)